Sara Delfanti

720 total citations
32 papers, 254 citations indexed

About

Sara Delfanti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Sara Delfanti has authored 32 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Sara Delfanti's work include Occupational and environmental lung diseases (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (5 papers). Sara Delfanti is often cited by papers focused on Occupational and environmental lung diseases (8 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (5 papers). Sara Delfanti collaborates with scholars based in Italy, Canada and United States. Sara Delfanti's co-authors include S. Mariucci, Marco Danova, Silvia Brugnatelli, B. Rovati, Paolo Pedrazzoli, Katia Bencardino, Carmine Tinelli, Marco Manzoni, Lorenzo Cobianchi and Alfredo Falcone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Sara Delfanti

30 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Delfanti Italy 10 116 95 58 43 34 32 254
Ping Ai China 10 76 0.7× 74 0.8× 70 1.2× 22 0.5× 42 1.2× 39 263
Adam Diehl United States 7 221 1.9× 69 0.7× 54 0.9× 54 1.3× 44 1.3× 16 299
Mario Occhipinti Italy 9 163 1.4× 88 0.9× 42 0.7× 51 1.2× 20 0.6× 34 237
Ariel E. Birnbaum United States 8 118 1.0× 119 1.3× 60 1.0× 17 0.4× 39 1.1× 25 284
J. Luna Spain 10 101 0.9× 121 1.3× 80 1.4× 16 0.4× 50 1.5× 23 322
Yaoxiong Xia China 13 122 1.1× 99 1.0× 139 2.4× 27 0.6× 133 3.9× 39 348
Dezuo Dong China 9 122 1.1× 77 0.8× 119 2.1× 27 0.6× 56 1.6× 20 283
Whitney S. Brandt United States 11 75 0.6× 208 2.2× 77 1.3× 23 0.5× 61 1.8× 29 320
Naoki Izawa Japan 9 189 1.6× 132 1.4× 83 1.4× 24 0.6× 31 0.9× 58 363
Ha Linh Vu United States 9 140 1.2× 102 1.1× 152 2.6× 46 1.1× 57 1.7× 10 499

Countries citing papers authored by Sara Delfanti

Since Specialization
Citations

This map shows the geographic impact of Sara Delfanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Delfanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Delfanti more than expected).

Fields of papers citing papers by Sara Delfanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Delfanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Delfanti. The network helps show where Sara Delfanti may publish in the future.

Co-authorship network of co-authors of Sara Delfanti

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Delfanti. A scholar is included among the top collaborators of Sara Delfanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Delfanti. Sara Delfanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cerbone, Linda, Sara Delfanti, Paola Barbieri, et al.. (2024). Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases. PubMed. 14(1). 2424133–2424133. 1 indexed citations
2.
Faccioli, Eleonora, Federica Grosso, Andrea Dell’Amore, et al.. (2024). Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report. Frontiers in Oncology. 14. 1378530–1378530. 1 indexed citations
3.
Cerbone, Luigi, Sara Delfanti, Marinella Bertolotti, et al.. (2023). Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens. Thoracic Cancer. 14(5). 524–527. 4 indexed citations
4.
Cerbone, Luigi, et al.. (2023). Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. Cancers. 15(24). 5716–5716. 1 indexed citations
5.
6.
Grosso, Federica, Paola Ferro, Antonella Vigani, et al.. (2021). Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score. Diagnostics. 11(11). 2015–2015. 4 indexed citations
7.
Grillo, Federica, Alessandro Vanoli, Sara Delfanti, et al.. (2019). Comparison of pathology sampling protocols for pancreatoduodenectomy specimens. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(5). 735–744. 6 indexed citations
8.
Vitolo, Viviana, Lorenzo Cobianchi, Silvia Brugnatelli, et al.. (2019). Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study. BMC Cancer. 19(1). 922–922. 29 indexed citations
9.
Aquilani, Roberto, Silvia Brugnatelli, Maurizia Dossena, et al.. (2019). Oxaliplatin-Fluoropyrimidine Combination (XELOX) Therapy Does Not Affect Plasma Amino Acid Levels and Plasma Markers of Oxidative Stress in Colorectal Cancer Surgery Patients: A Pilot Study. Nutrients. 11(11). 2667–2667. 10 indexed citations
10.
Perfetti, Vittorio, Erik Laurini, Suzana Aulić, et al.. (2017). Molecular and functional characterization of a new 3′ end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib. Oncotarget. 8(34). 56158–56167. 6 indexed citations
11.
Rovati, B., S. Mariucci, Sara Delfanti, et al.. (2016). Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy. Cellular Oncology. 39(3). 211–228. 7 indexed citations
12.
Gobbi, Paolo G., Sandro Rossi, Mario Comelli, et al.. (2015). The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments. Current Cancer Drug Targets. 15(6). 511–518. 2 indexed citations
13.
Pedrazzoli, Paolo, Massimo Martino, Sara Delfanti, et al.. (2015). High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer. JNCI Monographs. 2015(51). 70–75. 9 indexed citations
14.
Rovati, B., et al.. (2013). An eight-colour flow cytometric method for the detection of reference values of lymphocyte subsets in selected healthy donors. Clinical and Experimental Medicine. 14(3). 249–259. 8 indexed citations
15.
Mariucci, S., Sara Delfanti, B. Rovati, et al.. (2012). Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(7). 1187–1196. 27 indexed citations
16.
Danova, Marco, Sara Delfanti, Marco Manzoni, & S. Mariucci. (2011). Tissue and Soluble Biomarkers in Breast Cancer and Their Applications: Ready to Use?. JNCI Monographs. 2011(43). 75–78. 11 indexed citations
17.
Mariucci, S., B. Rovati, Matteo Giovanni Della Porta, et al.. (2010). Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors. Clinical and Experimental Medicine. 11(4). 199–210. 11 indexed citations
18.
Delfanti, Sara, B. Rovati, Donatella Grasso, et al.. (2009). Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens. Clinical and Experimental Medicine. 10(2). 135–138. 3 indexed citations
19.
Bencardino, Katia, Marco Manzoni, Sara Delfanti, et al.. (2007). Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. Internal and Emergency Medicine. 2(1). 3–12. 12 indexed citations
20.
Manzoni, M., Katia Bencardino, Franco Piovella, et al.. (2007). New agents in medical oncology and the risk of venous thromboembolism.. PubMed. 26(2). 185–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Ai Breakdown of academic impact, for papers by Adam Diehl Breakdown of academic impact, for papers by Mario Occhipinti Breakdown of academic impact, for papers by Ariel E. Birnbaum Breakdown of academic impact, for papers by J. Luna Breakdown of academic impact, for papers by Yaoxiong Xia Breakdown of academic impact, for papers by Dezuo Dong Breakdown of academic impact, for papers by Whitney S. Brandt Breakdown of academic impact, for papers by Naoki Izawa Breakdown of academic impact, for papers by Ha Linh Vu
Rankless by CCL
2026